JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds
Signaling Pathways

Signaling Pathways

A8803 RGFP966
4 Citation

Target: Histone Deacetylases (HDACs)

Summary: Specific HDAC3 inhibitor

insoluble in H2O; ≥18.12 mg/mL
A1124 Amyloid Beta-Peptide (1-40) (human)
1 Citation

Summary: residues 1-40 of human amyloid-beta

insoluble in EtOH; ≥23.8 mg/mL
B7945 Urolithin A

≥22.8 mg/mL
B5965 Tamoxifen
17 Citation

Target: PKC

Summary: estrogen receptor modulator

≥18.6 mg/mL
B6052 Nitrocefin
2 Citation

Summary: chromogenic substrate of β-lactamase enzymes

insoluble in EtOH; insoluble in H2O; ≥20.24 mg/mL
C3213 Oleandomycin

Summary: macrolide antibiotic

Soluble in DMSO
C4087 Mebendazole

Summary: broad-spectrum anthelmintic that inhibits intestinal microtubule synthesis

insoluble in H2O; insoluble in EtOH; ≥13 mg/mL
A4412 MDL 28170
2 Citation

Target: Cathepsins|Calpains

Summary: Calpain and cathepsin B inhibitor, selective

insoluble in H2O; ≥16.75 mg/mL
A8207 AZD6244 (Selumetinib)
6 Citation

Summary: MEK inhibitor

≥22.88 mg/mL
A8244 Cycloheximide
54 Citation

Summary: protein biosynthesis inhibitor

≥14.05 mg/mL